Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/1998
01/22/1998CA2259927A1 Chemokine receptor antagonists and methods of use therefor
01/21/1998EP0819673A1 Cyanamide salts as bleach activators
01/21/1998EP0819672A2 Hydroxamic acid derivatives and their use for improving latent image stability of a silver halide photographic material
01/21/1998EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
01/21/1998EP0625977B1 Piperazine derivatives as 5-ht1a antagonists
01/20/1998US5710169 Therapeutic heterocycles
01/20/1998US5710155 Arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
01/20/1998US5710149 Piperazine derivatives as 5-ht antagonists
01/15/1998WO1998001434A1 New piperazine derivatives and oxydation dyes
01/15/1998WO1998001132A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
01/14/1998EP0817778A1 Reversible protease inhibitors
01/14/1998EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process
01/14/1998EP0817643A1 Compounds and compositions for delivering active agents
01/14/1998EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors
01/14/1998CN1170405A Aryl-and hetaryl-sulfonamide derivatives, their perparation and their use as endothelin antagonists
01/13/1998US5708186 Stereoselective process
01/13/1998US5708172 Intermediates for synthetic use and processes for producing aminopiperazine derivatives
01/13/1998US5708032 Fluoroalkenyl compounds and their use as pest control agents
01/13/1998US5708018 2-aminoindans as selective dopamine D3 ligands
01/13/1998US5708006 Neurokinin antagonists
01/13/1998US5708004 Retroviral protease inhibitors
01/13/1998US5707994 2,3-diaminopropionic acid derivative
01/13/1998US5707985 Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators
01/13/1998US5707649 Using a 2-acylaminopropanol derivative
01/12/1998CA2180993A1 Methods for the manufacture of cetirizine
01/08/1998WO1998000589A1 Process for preparation of an aqueous solution of n-methylmorpholin-n-oxide
01/08/1998WO1998000412A1 Muscarinic antagonists
01/08/1998WO1998000402A1 Piperazine derivatives and process for the preparation thereof
01/08/1998WO1998000401A1 Fibrinogen receptor antagonist prodrugs
01/08/1998WO1998000398A1 Method for the synthesis of amines and amino acids with organoboron derivatives
01/08/1998WO1998000144A1 Fibrinogen receptor antagonist prodrugs
01/08/1998WO1998000141A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-trihexyphenidyl
01/08/1998WO1998000134A1 Fibrinogen receptor antagonists
01/08/1998DE19728336A1 Hair dyeing composition containing direct 2-nitro-aniline dye
01/08/1998DE19728335A1 New tetra:amino N,N'-di:phenyl-piperazine derivatives
01/08/1998CA2258093A1 Fibrinogen receptor antagonists
01/08/1998CA2257950A1 Fibrinogen receptor antagonist prodrugs
01/08/1998CA2257937A1 Fibrinogen receptor antagonist prodrugs
01/08/1998CA2230050A1 Process for preparation of an aqueous solution of n-methylmorpholin-n-oxide
01/07/1998EP0816351A1 Functional N-vinylformamides, process for their preparation and their use in free radical polymerisation reactions
01/07/1998EP0816350A1 Process for the preparation of N-substituted cyclic amines
01/07/1998EP0816310A2 Scavenger assisted combinatorial process for preparing libraries of tertiary amine compounds
01/07/1998EP0815856A2 Retroviral protease inhibitors
01/07/1998EP0815103A1 Trypsin and thrombin inhibitors
01/07/1998EP0815074A1 O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
01/07/1998EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
01/07/1998EP0783460B1 Method of processing an aqueous solution in the amine oxide process
01/07/1998EP0613458B1 Acyclic ethylenediamine derivatives as substance p receptor antagonists
01/07/1998EP0592490B1 Amino acid derivative anticonvulsant
01/07/1998CN1169714A Butanedioic acid derivative and their use as surfactants
01/06/1998US5705658 Azido containing tetrahydro furan compounds
01/06/1998US5705648 Mepiquat chloride
01/06/1998US5705640 Analgesics, antidepressants, anxiolytic agents
01/06/1998US5705586 Organic fluorine compounds and curable compositions
01/06/1998US5705529 N-benzoyl amino acid derivatives pharmaceutical compositions containing them and process for preparing same
01/06/1998US5705519 Method for treating 5-HT2B receptor related conditions
01/06/1998US5705501 Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease
01/06/1998US5705188 Lipid mixture, antitumor agents
01/06/1998US5705167 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders
01/02/1998CA2208815A1 Functional n-vinylformamides
12/1997
12/31/1997WO1997049682A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/31/1997WO1997049674A1 Matrix metalloproteinase inhibitors
12/31/1997WO1997049673A1 Selective thrombin inhibitors
12/31/1997WO1997049433A1 Fluoro labelled anthracyclinone and anthracycline derivatives
12/31/1997CN1169141A Novel amine derivative, process for producing same, and use thereof as antiarrhythmic
12/31/1997CN1169116A Method for inhibiting environmental estrogens
12/31/1997CN1169098A Crop protective products
12/31/1997CA2258630A1 Fluoro labelled anthracyclinone and anthracycline derivatives for treatment and diagnosis of amyloidosis
12/31/1997CA2257404A1 Matrix metalloproteinase inhibitors
12/30/1997US5703237 N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
12/30/1997US5703235 N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
12/30/1997US5703083 Therapy for psychological disorders
12/30/1997US5703082 Enantiomers of 1- (4-chlorophenyl)phenylmethyl!- (4-methylphenyl)sulfonyl!pi
12/30/1997US5703076 Retroviral protease inhibitors
12/30/1997US5703071 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
12/30/1997US5702866 Dihydrazides
12/30/1997CA2024479C Quinone derivatives and pharmacological use
12/30/1997CA2007385C Process for the optical resolution of dropropizine
12/29/1997EP0814082A1 Enolethers and their use as a fungicide
12/29/1997EP0814081A1 Drug resistance and multidrug resistance modulators
12/29/1997EP0813868A2 Retroviral protease inhibitors
12/29/1997EP0813867A2 Retroviral protease inhibitors
12/29/1997EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity
12/29/1997EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives
12/29/1997EP0787153B1 Process for re-using an aqueous process fluid from the amine oxide process
12/24/1997WO1997048689A1 Drug resistance and multidrug resistance modulators
12/24/1997WO1997048676A1 Triphenylalkyl antimicrobial agents
12/24/1997WO1997048675A1 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
12/24/1997CN1168633A Boronic ester and acid compounds, synthesis and uses
12/24/1997CN1168376A Process for preparing sildenafil
12/24/1997CA2258556A1 Drug resistance and multidrug resistance modulators
12/23/1997US5700840 Fluoroalkenyl compounds and their use as pest control agents
12/23/1997US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors
12/23/1997US5700830 Prevention adhesion of cancerous cells and noncancerous structures in mammals
12/23/1997US5700811 Potent inducers of terminal differentiation and method of use thereof
12/23/1997US5700801 Antiinflammatory agents, bone disorders
12/23/1997CA2008391C 1,2-cyclohexylaminoaryl amides useful as analgesic agents
12/18/1997WO1997047592A1 Pesticides
12/18/1997WO1997047194A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
12/17/1997EP0812866A1 Storage stable moisture-curing adhesive composition